Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Multiple Myeloma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1980 2019

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: A randomized phase 2 study

Strati, P., Fanale, M. A., Oki, Y., Turturro, F., Fayad, L. E., Bartlett, N. L., Gladstone, D. E., Kasamon, Y. L., Portlock, C. S., Wilson, W. H., Goy, A., Younes, A. & Lee, H. J., Jan 31 2019, In : Haematologica. 104, 2, p. e65-e67

Research output: Contribution to journalLetter

Hodgkin Disease
Rituximab

Acalabrutinib for adults with mantle cell lymphoma

Jurczak, W., Długosz-Danecka, M. & Wang, L., Mar 4 2019, In : Expert Review of Clinical Pharmacology. 12, 3, p. 179-187 9 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cell- and Tissue-Based Therapy
1-Phosphatidylinositol 4-Kinase
B-Cell Lymphoma
Therapeutic Uses

Acute myeloid leukemia with eosinophilia after cyclin-dependent kinases 4/6 inhibitor treatment due to underlying clonal hematopoiesis of indeterminate potential

Anand, K., Kumar, P., Pingali, S. R., Pati, D. & Iyer, S. P., Mar 1 2019, In : American journal of hematology. 94, 3, p. E82-E85

Research output: Contribution to journalLetter

Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase 4
Hematopoiesis
Eosinophilia
Acute Myeloid Leukemia